Zusammenfassung
Amalgam, welches weltweit seit 150 Jahren als Zahnfüllmaterial verwendet wird, besteht aus etwa 50 % elementarem Quecksilber und einer Mischung aus Silber, Zinn, Kupfer und Zink. Aus fertigen Amalgamfüllungen werden kontinuierlich kleine Mengen an Quecksilberdampf freigesetzt. Amalgam trägt dabei signifikant zur menschlichen Quecksilberbelastung bei. Quecksilber kann in Organen, insbesondere im Gehirn akkumulieren, da die Bindung zu Proteinen stärker als die von anderen Schwermetallen (z. B. Blei, Kadmium) ist. Im Gehirn werden Halbwertszeiten von 1 - 18 Jahren angenommen. Quecksilber gilt als eines der giftigsten nichtradioaktiven Elemente. Es bestehen Hinweise darauf, dass Quecksilberdampf stärker neurotoxisch wirkt als Methyl-Quecksilber aus Fisch. Neuere Publikationen weisen auf das Risiko von Nierenschädigungen, neuropsychologischen Beeinträchtigungen, Induktion von Autoimmunerkrankungen oder Sensibilisierungen, gesteigerte oxidative Belastung, Autismus, Haut- und Schleimhautreaktionen und unspezifische Beschwerden durch Amalgamexposition hin. Auch die Alzheimer-Erkrankung oder die Entwicklung einer MS wird z. T. mit einer Quecksilberexposition in Zusammenhang gebracht. Es bestehen, möglicherweise erblich bedingt oder erworben, unterschiedliche interindividuelle Empfindlichkeiten zur Entstehung von negativen Effekten durch Amalgambelastungen. Quecksilbermessungen in Biomarkern sind aufgrund fehlender Korrelation zu den Quecksilberkonzentrationen in den Organen nur bedingt zur Abschätzung der Quecksilberbelastung der kritischen Organe geeignet. Wegen methodischer Mängel sind manche Amalgamstudien in ihren Aussagen nur bedingt verwertbar. Eine Amalgamentfernung konnte in einigen Studien bei einem relevanten Teil der Patienten zur dauerhaften Verbesserung oder Heilung verschiedener und meistens chronischer Beschwerden führen. Aufgrund der Berücksichtigung aller verfügbaren Daten kann Amalgam weder medizinisch, arbeitsmedizinisch noch ökologisch als sicheres Zahnfüllungsmaterial bezeichnet werden.
Abstract
Amalgam, which has been in use in dentistry for 150 years, consists of 50 % elemental mercury and a mixture of silver, tin, copper and zinc. Minute amounts of mercury vapour are released continuously from amalgam. Amalgam contributes substantially to human mercury load. Mercury accumulates in some organs, particulary in the brain, where it can bind to protein more tightly than other heavy metals (e. g. lead, cadmium). Therefore, the elimination half time is assumed to be up to 1 - 18 years in the brain and bones. Mercury is assumed to be one of the most toxic non-radioactive elements. There are pointers to show that mercury vapour is more neurotoxic than methyl-mercury in fish. Review of recent literature suggests that mercury from dental amalgam may lead to nephrotoxicity, neurobehavioural changes, autoimmunity, oxidative stress, autism, skin and mucosa alterations or non-specific symptoms and complaints. The development of Alzheimer’s disease or multiple sclerosis has also been linked to low-dose mercury exposure. There may be individual genetical or acquired susceptilities for negative effects from dental amalgam. Mercury levels in the blood, urine or other biomarkers do not reflect the mercury load in critical organs. Some studies regarding dental amalgam reveal substantial methodical flaws. Removal of dental amalgam leads to permanent improvement of various chronic complaints in a relevant number of patients in various trials. Summing up, available data suggests that dental amalgam is an unsuitable material for medical, occupational and ecological reasons.
Schlüsselwörter
Amalgam - Quecksilber - Toxizität - Nebenwirkungen - Autoimmunität - Neurodegenerative Krankheiten
Key words
Amalgam - mercury - toxicity - adverse health effects - autoimmunity - neurodegenerative diseases
Literatur
-
1
Nickolaus B.
Einen sanften Ausstieg vorbereiten.
Deutsches Ärzteblatt.
1995;
92
1/2
-
2
Kommission Human-Biomonitoring des Umweltbundesamtes .
Stoffmonographie Quecksilber - Referenz- und Human-Biomonitoring-Werte (HBM).
Bundesgesundhbl.
1999;
42
522-532
-
3
van Steenkiste M, Becher A, Banschbach R. et al .
Prevalence of Caries, Fissure Sealants and Filling Materials among German Children and Children of Migrants.
Gesundheitswesen.
2004;
66
754-758
-
4
Gabrio T, Benedikt G, Broser S. et al .
10 years of observation by public health offices in Baden-Wurttemberg - assessment of human biomonitoring for mercury due to dental amalgam fillings and other sources.
Gesundheitswesen.
2003;
65
327-335
-
5
Tiffany-Castiglion E, Qian Y.
Astroglia as metal depots: molecular mechanisms for metal accumulation, storage and release.
Neurotoxicology.
2001;
22
577-592
-
6
Lorscheider F L, Vimy M J, Summers A O.
Mercury exposure from „silver” tooth fillings: emerging evidence questions a traditional dental paradigm.
FASEB J.
1995;
9
504-508
-
7
Arvidson B.
Inorganic mercury is transported from muscular nerve terminals to spinal and brainstem motoneurons.
Muscle Nerve.
1992;
15
1089-1094
-
8
Arvidson B.
A review of axonal transport of metals.
Toxicology.
1994;
88
1-14
-
9
Arvidson B, Arvidsson J.
Retrograde axonal transport of mercury in primary sensory neurons innervating the tooth pulp in the rat.
Neurosci Lett.
1990;
115
29-32
-
10
Arvidson B, Arvidsson J, Johansson K.
Mercury deposits in neurons of the trigeminal ganglia after insertion of dental amalgam in rats.
Biometals.
1994;
7
261-263
-
11
Stortebecker P.
Mercury poisoning from dental amalgam through a direct nose-brain transport.
Lancet.
1989;
1
1207
-
12
Pamphlett R, Coote P.
Entry of low doses of mercury vapor into the nervous system.
Neurotoxicology.
1998;
19
39-47
-
13
Tjalve H, Henriksson J.
Uptake of metals in the brain via olfactory pathways.
Neurotoxicology.
1999;
20
181-195
-
14
Akyuz S, Caglar E.
Pulpal uptake of mercury from lined amalgam restorations in guinea pigs.
Eur J Oral Sci.
2002;
110
460-463
-
15 WHO (World Health Organisation) (ed) .Environmental Health Criteria 118: Inorganic mercury. Geneva; 1991
-
16
Danscher G, Horsted-Bindslev P, Rungby J.
Traces of mercury in organs from primates with amalgam fillings.
Exp Mol Pathol.
1990;
52
291-299
-
17
Galic N, Prpic-Mehicic G, Prester L. et al .
Dental amalgam mercury exposure in rats.
Biometals.
1999;
12
227-231
-
18
Galic N, Prpic-Mehiic G, Prester L J. et al .
Elimination of mercury from amalgam in rats.
J Trace Elem Med Biol.
2001;
15
1-4
-
19
Hahn L J, Kloiber R, Leininger R W. et al .
Whole-body imaging of the distribution of mercury released from dental fillings into monkey tissues.
FASEB J.
1990;
4
3256-3260
-
20
Hahn L J, Kloiber R, Vimy M J. et al .
Dental „silver” tooth fillings: a source of mercury exposure revealed by whole-body image scan and tissue analysis.
FASEB J.
1989;
3
2641-2646
-
21
Lorscheider F L, Vimy M J.
Mercury exposure from „silver” fillings.
Lancet.
1991;
337
1103
-
22
Vimy M J, Takahashi Y, Lorscheider F L.
Maternal-fetal distribution of mercury (203Hg) released from dental amalgam fillings.
Am J Physiol.
1990;
258
939-945
-
23
Barany E, Bergdahl I A, Bratteby L E. et al .
Mercury and selenium in whole blood and serum in relation to fish consumption and amalgam fillings in adolescents.
J Trace Elem Med Biol.
2003;
17
165-170
-
24
Barregard L, Svalander C, Schutz A. et al .
Cadmium, mercury, and lead in kidney cortex of the general Swedish population: a study of biopsies from living kidney donors.
Environ Health Perspect.
1999;
107
867-871
-
25
Becker K, Kaus S, Krause C. et al .
German Environmental Survey 1998 (GerES III): environmental pollutants in blood of the German population.
Int J Hyg Environ Health.
2002;
205
297-308
-
26
Becker K, Schulz C, Kaus S. et al .
German Environmental Survey 1998 (GerES III): environmental pollutants in the urine of the German population.
Int J Hyg Environ Health.
2003;
206
15-24
-
27
Drasch G, Schupp I, Hofl H. et al .
Mercury burden of human fetal and infant tissues.
Eur J Pediatr.
1994;
153
607-610
-
28
Drasch G, Schupp I, Riedl G. et al .
Einfluß von Amalgamfüllungen auf die Quecksilberkonzentration in menschlichen Organen.
Dtsch Zahnärztl Z.
1992;
47
490-496
-
29
Drasch G, Wanghofer E, Roider G.
Are blood, urine, hair, and muscle valid bio-monitoring parameters for the internal burden of men with the heavy metals mercury, lead and cadmium?.
Trace Elem Electrolytes.
1997;
14
116-123
-
30
Eggleston D W, Nylander M.
Correlation of dental amalgam with mercury in brain tissue.
J Prosthet Dent.
1987;
58
704-707
-
31
Gottwald B, Traenckner I, Kupfer J. et al .
Gieler „Amalgam disease” - poisoning, allergy, or psychic disorder?.
Int J Hyg Environ Health.
2001;
204
223-930
-
32
Guzzi G, Grandi M, Cattaneo C.
Should amalgam fillings be removed?.
Lancet.
2002;
360
2081
-
33
Mortada W I, Sobh M A, El-Defrawy M M. et al .
Mercury in dental restoration: Is there a risk of nephrotoxicity?.
J Nephrol.
2002;
15
171-176
-
34
Nylander M.
Mercury in pituitary glands of dentists.
Lancet.
1986;
1
442
-
35
Nylander M, Friberg L, Lind B.
Mercury concentrations in the human brain and kidneys in relation to exposure from dental amalgam fillings.
Swed Dent J.
1987;
11
179-187
-
36
Nylander M, Weiner J.
Mercury and selenium concentrations and their interrelations in organs from dental staff and the general population.
Br J Ind Med.
1991;
48
729-734
-
37
Pizzichini M, Fonzi M, Giannerini F. et al .
Influence of amalgam fillings on Hg levels and total antioxidant activity in plasma of healthy donors.
Sci Total Environ.
2003;
301
43-50
-
38
Weiner J A, Nylander M.
The relationship between mercury concentration in human organs and different predictor variables.
Sci Total Environ.
1993;
138
101-115
-
39
Zimmer H, Ludwig H, Bader M. et al .
Determination of mercury in blood, urine and saliva for the biological monitoring of an exposure from amalgam fillings in a group with self-reported adverse health effects.
Int J Hyg Environ Health.
2002;
205
205-211
-
40
Kingman A, Albertini T, Brown L J.
Mercury concentrations in urine and whole blood associated with amalgam exposure in a US military population.
J Dent Res.
1998;
77
461-471
-
41
Mutter J, Naumann J.
Mercury and the risk of myocardial infarction.
N Engl J Med.
2003;
348
2151-2154
-
42
Drasch G, Muller R K, Grasemann F. et al .
Comparison of the body burden of the population of Leipzig and Munich with the heavy metals cadmium, lead and mercury - a study of human organ samples.
Gesundheitswesen.
1994;
56
263-267
-
43
Ask K, Akesson A, Berglund M. et al .
Inorganic mercury and methylmercury in placentas of Swedish women.
Environ Health Perspect.
2002;
110
523-526
-
44
Holmes A S, Blaxill M F, Haley B E.
Reduced levels of mercury in first baby haircuts of autistic children.
Int J Toxicol.
2003;
22
277-285
-
45
Morgan D L, Chanda S M, Price H C. et al .
Disposition of inhaled mercury vapor in pregnant rats: maternal toxicity and effects on developmental outcome.
Toxicol Sci.
2002;
66
261-273
-
46
Takahashi Y, Tsuruta S, Hasegawa J. et al .
Release of mercury from dental amalgam fillings in pregnant rats and distribution of mercury in maternal and fetal tissues.
Toxicology.
2001;
163
115-126
-
47
Takahashi Y, Tsuruta S, Arimoto M. et al .
Placental transfer of mercury in pregnant rats which received dental amalgam restorations.
Toxicology.
2003;
185
23-33
-
48
Vahter M, Akesson A, Lind B. et al .
Longitudinal study of methylmercury and inorganic mercury in blood and urine of pregnant and lactating women, as well as in umbilical cord blood.
Environ Res.
2000;
84
186-194
-
49
Yoshida M, Satoh M, Shimada A. et al .
Maternal-to-fetus transfer of mercury in metallothionein-null pregnant mice after exposure to mercury vapor.
Toxicology.
2002;
175
215-222
-
50
Yoshida M.
Placental to fetal transfer of mercury and fetotoxicity.
Tohoku J Exp Med.
2002;
196
79-88
-
51
Drasch G, Aigner S, Roider G. et al .
Mercury in human colostrum and early breast milk. Its dependence on dental amalgam and other factors.
J Trace Elem Med Biol.
1998;
12
23-27
-
52
Oskarsson A, Schultz A, Skerfving S. et al .
Total and inorganic mercury in breast milk in relation to fish consumption and amalgam in lactating women.
Arch Environ Health.
1996;
51
234-241
-
53
Vimy M J, Hooper D E, King W W. et al .
Mercury from maternal „silver” tooth fillings in sheep and human breast milk. A source of neonatal exposure.
Biol Trace Elem Res.
1997;
56
143-152
-
54
Leistevuo J, Leistevuo T, Helenius H. et al .
Dental amalgam fillings and the amount of organic mercury in human saliva.
Caries Res.
2001;
35
163-166
-
55
Heintze U, Edwardsson S, Derand T. et al .
Methylation of mercury from dental amalgam and mercuric chloride by oral streptococci in vitro.
Scand J Dent Res.
1983;
91
150-152
-
56
Yannai S, Berdicevsky I, Duek L.
Transformations of inorganic mercury by Candida albicans and Saccharomyces cerevisiae.
Appl Environ Microbiol.
1991;
57
245-247
-
57
Wang J, Liu Z.
[In vitro Study of Strepcoccus Mutans in the Plaque on the Surface of Amalgam Fillings on the Convertion of Inorganic Mercury to Organic Mercury].
Shanghai Kou Qiang Yi Xue.
2000;
9
70-72
-
58
Dodes J E.
The amalgam controversy. An evidence-based analysis.
J Am Dent Assoc.
2001;
132
348-356
-
59
Jones D W.
Exposure or absorption and the crucial question of limits for mercury.
J Can Dent Assoc.
1999;
65
42-46
-
60
Larkin M.
Don’t remove amalgam fillings, urges American Dental Association.
Lancet.
2002;
3
360
-
61
Wahl M J.
A biocompatible material for the new millennium: dental amalgam.
Dent Today.
2001;
20
16
-
62
Wahl M J.
A resin alternative for posterior teeth: questions and answers on dental amalgam.
Dent Update.
2003;
30
256-262
-
63
Wahl M J.
Amalgam revisited.
Dent Today.
2002;
21
16, 18
-
64
Wahl M J.
Amalgam - Resurrection and redemption. Part 1: the clinical and legal mythology of anti-amalgam.
Quintessence Int.
2001;
32
525-535
-
65
Wahl M J.
Amalgam - resurrection and redemption. Part 2: The medical mythology of anti-amalgam.
Quintessence Int.
2001;
32
696-710
-
66
Hargreaves R J, Evans J G, Janota I. et al .
Persistent mercury in nerve cells 16 years after metallic mercury poisoning.
Neuropathol Appl Neurobiol.
1988;
14
443-452
-
67
Kosta L, Byrne A R, Zelenko V.
Correlation between selenium and mercury in man following exposure to inorganic mercury.
Nature.
1975;
254
238-239
-
68
Opitz H, Schweinsberg F, Grossmann T. et al .
Demonstration of mercury in the human brain and other organs 17 years after metallic mercury exposure.
Clin Neuropathol.
1996;
15
139-144
-
69
Sugita M.
The biological half-time of heavy metals. The existence of a third, „slowest” component.
Int Arch Occup Environ Health.
1978;
41
25-40
-
70
Duhr E F, Pendergrass J C, Slevin J T. et al .
HgEDTA complex inhibits GTP interactions with the E-site of brain beta-tubulin.
Toxicol Appl Pharmacol.
1993;
122
273-280
-
71 Pendergrass J C, Haley B E. Inhibition of Brain Tubulin-Guanosine 5’-Triphosphate Interactions by Mercury: Similarity to Observations in Alzheimer’s Diseased Brain. Sigel H, Sigel A, Dekker M Metal Ions in Biological Systems V34. Mercury and Its Effects on Environment and Biology New York; Inc. 270 Madison Ave 1996 chapter 16: 461-478,
-
72
Soares F A, Farina M, Santos F W. et al .
Interaction between metals and chelating agents affects glutamate binding on brain synaptic membranes.
Neurochem Res.
2003;
28
1859-1865
-
73
Aposhian H V, Morgan D L, Queen H L. et al .
Vitamin C, glutathione, or lipoic acid did not decrease brain or kidney mercury in rats exposed to mercury vapor.
J Toxicol Clin Toxicol.
2003;
41
339-347
-
74
Ewan K B, Pamphlett R.
Increased inorganic mercury in spinal motor neurons following chelating agents.
Neurotoxicology.
1996;
17
34 334-34 339
-
75
Nogueira C W, Soares F A, Nascimento P C. et al .
2,3-Dimercaptopropane-1-sulfonic acid and meso-2,3-dimercaptosuccinic acid increase mercury- and cadmium-induced inhibition of delta-aminolevulinate dehydratase.
Toxicology.
2003;
184
85-95
-
76
Harris H H, Pickering I J, George G N.
The chemical form of mercury in fish.
Science.
2003;
301 (5637)
1203
-
77
Fredriksson A, Dencker L, Archer T. et al .
Prenatal coexposure to metallic mercury vapour and methylmercury produce interactive behavioural changes in adult rats.
Neurotoxicol Teratol.
1996;
18
129-134
-
78
Drasch G, Bose-O’Reilly S, Beinhoff C. et al .
The Mt. Diwata study on the Philippines 1999 - assessing mercury intoxication of the population by small scale gold mining.
Sci Total Environ.
2001;
267
151-168
-
79
Drasch G, Bose-O’Reilly S, Maydl S. et al .
Scientific comment on the German human biological monitoring values (HBM values) for mercury.
Int J Hyg Environ Health.
2002;
205
509-512
-
80
Schubert J, Riley E J, Tyler S A.
Combined effects in toxicology - a rapid systematic testing procedure: cadmium, mercury, and lead.
J Toxicol Environ Health.
1978;
4
763-776
-
81
Viola P, Cassano G B.
The effect of chlorine on mercury vapor intoxication. Autoradiographic study.
Med Lavoro.
1968;
59
437-444
-
82
Kommission Human Biomonitoring .
Commentary regarding the article by Drasch et al. Scientific comment on the German human biological monitoring values (HBM values) for mercury.
Int J Hyg Environ Health.
2004;
207
179-181
-
83
Drasch G, Bose-Reilly S, Mydl S. et al .
Response to the letter of the Human Biomonitoring Commission.
Int J Hyg Environ Health.
2004;
207
183-184
-
84
Bellinger D C, Needleman H L.
Intellectual impairment and blood lead levels.
N Engl J Med.
2003;
349
500-502
-
85
Walkowiak J, Altmann L, Kramer U. et al .
Cognitive and sensorimotor functions in 6-year-old children in relation to lead and mercury levels: adjustment for intelligence and contrast sensitivity in computerized testing.
Neurotoxicol Teratol.
1998;
20
511-521
-
86
Rogan W J, Ware J H.
Exposure to lead in children - how low is low enough?.
N Engl J Med.
2003;
348
1515-1516
-
87
Canfield R L, Henderson C R Jr, Cory-Slechta D A. et al .
Intellectual impairment in children with blood lead concentrations below 10 microg per deciliter.
N Engl J Med.
2003;
348
1517-1526
-
88
Selevan S G, Rice D C, Hogan K A. et al .
Blood lead concentration and delayed puberty in girls.
Bethel J. N Engl J Med.
2003;
348
1527-1536
-
89
Lin J L, Lin-Tan D T, Hsu K H. et al .
Environmental lead exposure and progression of chronic renal diseases in patients without diabetes.
N Engl J Med.
2003;
348
277-286
-
90
Glenn B S, Stewart W F, Links J M. et al .
The longitudinal association of lead with blood pressure.
Epidemiology.
2003;
14
30-36
-
91
Boyd N D, Benediktsson H, Vimy M J. et al .
Mercury from dental „silver” tooth fillings impairs sheep kidney function.
Am J Physiol.
1991;
261
R1010-R1014
-
92
Pollard K M, Pearson D L, Hultman P. et al .
Xenobiotic acceleration of idiopathic systemic autoimmunity in lupus-prone bxsb mice.
Environ Health Perspect.
2001;
109
27-33
-
93
Akiyama M, Oshima H, Nakamura M.
Genotoxicity of mercury used in chromosome aberration tests.
Toxicol In Vitro.
2001;
15
463-467
-
94
Pizzichini M, Fonzi M, Sugherini L. et al .
Release of mercury from dental amalgam and its influence on salivary antioxidant activity.
Bull Group Int Rech Sci Stomatol Odontol.
2000;
42
94-100
-
95
Pizzichini M, Fonzi M, Sugherini L. et al .
Release of mercury from dental amalgam and its influence on salivary antioxidant activity.
Sci Total Environ.
2002;
284
19-25
-
96
Pizzichini M, Fonzi M, Gasparoni A. et al .
Influence of amalgam fillings on Hg levels and total antioxidant activity in plasma of healthy donors.
Bull Group Int Rech Sci Stomatol Odontol.
2001;
43
62-67
-
97
Olivieri G, Brack C, Muller-Spahn F. et al .
Mercury induces cell cytotoxicity and oxidative stress and increases beta-amyloid secretion and tau phosphorylation in SHSY5Y neuroblastoma cells.
J Neurochem.
2000;
74
231-236
-
98
Olivieri G, Novakovic M, Savaskan E. et al .
The effects of beta-estradiol on SHSY5Y neuroblastoma cells during heavy metal induced oxidative stress, neurotoxicity and beta-amyloid secretion.
Neuroscience.
2002;
113
849-855
-
99
Drasch G, Mail d er S, Schlosser C. et al .
Content of non-mercury-associated selenium in human tissues.
Biol Trace Elem Res.
2000;
77
219-230
-
100
Bartova J, Prochazkova J, Kratka Z. et al .
Dental amalgam as one of the risk factors in autoimmune diseases.
Neuroendocrinol Lett.
2003;
24
65-67
-
101 Berlin M. Mercury in dental-filling materials - an updated risk analysis in environmental medical terms. The dental Material Commission - Care and Consideration. 2003. Available from: URL: http://www.dentalmaterial.gov.se/mercury.pdf [cited 2003 September 22].
-
102
Hultman P, Johansson U, Turley S J. et al .
Adverse immunological effects and autoimmunity induced by dental amalgam and alloy in mice.
FASEB J.
1994;
8
1183-1190
-
103
Hultman P, Lindh U, Horsted-Bindslev P.
Activation of the immune system and systemic immune-complex deposits in Brown Norway rats with dental amalgam restorations.
J Dent Res.
1998;
77
1415-1425
-
104
Pollard K M, Pearson D L, Hultman P. et al .
Xenobiotic acceleration of idiopathic systemic autoimmunity in lupus-prone bxsb mice.
Environ Health Perspect.
2001;
109
27-33
-
105
Stejskal J, Stejskal V D.
The role of metals in autoimmunity and the link to neuroendocrinology.
Neuroendocrinol Lett.
1999;
20
351-364
-
106
Stejskal V D, Danersund A, Lindvall A. et al .
Metal-specific lymphocytes: biomarkers of sensitivity in man.
Neuroendocrinol Lett.
1999;
20
289-298
-
107
Sterzl I, Prochazkova J, Hrda P. et al .
Mercury and nickel allergy: risk factors in fatigue and autoimmunity.
Neuroendocrinol Lett.
1999;
20
221-228
-
108
Via C S, Nguyen P, Niculescu F. et al .
Low-dose exposure to inorganic mercury accelerates disease and mortality in acquired murine lupus.
Environ Health Perspect.
2003;
111
1273-1277
-
109
Kazantzis G.
Mercury exposure and early effects: an overview.
Med Lav.
2002;
93
139-147
-
110
Marcusson J A.
The frequency of mercury intolerance in patients with chronic fatigue syndrome and healthy controls.
Contact Dermatitis.
1999;
41
60-61
-
111 Richardson G M. Assesment of Mercury Exposure and Risks from Dental amalgam. Final Report. Medical Devices Bureau, Health. Canada. Ottawa; 1995
-
112
Björklund G.
Mercury as a potential source for the etiology of Alzheimer’s disease.
Trace Elem Med.
1991;
8
208
-
113
Ely J T.
Mercury induced Alzheimer’s disease: accelerating incidence?.
Bull Environ Contam Toxicol.
2001;
67
800-806
-
114 Haley B. The relationship of toxic effects of mercury to exacerbation of the medical condition classified as Alzheimer’s disease.2002. Available from: URL: http://www.fda.gov/ohrms/dockets/dailys/02/Sep02/091 602/80027dd5.pdf [cited 2004 November 17].
-
115
Mutter J, Naumann J, Sadaghiani C. et al .
Alzheimer Disease: Mercury as pathogenetic factor and apolipoprotein E as a moderator.
Neuroendocrin Lett.
2004;
25 (5)
275-283
-
116
Palkiewicz P, Zwiers H, Lorscheider F L.
ADP-ribosylation of brain neuronal proteins is altered by in vitro and in vivo exposure to inorganic mercury.
J Neurochem.
1994;
62
2049-2052
-
117
Pendergrass J C, Haley B E.
Inhibition of brain tubulin-guanosine 5’-triphosphate interactions by mercury: similarity to observations in Alzheimer’s diseased brain.
Met Ions Biol Syst.
1997;
34
461-478
-
118 Pendergrass J C, Haley B E. Mercury-EDTA Complex Specifically Blocks Brain-Tubulin-GTP Interactions: Similarity to Observations in Alzheimer’s Disease. Friberg LT, Schrauzer GN Status Quo and Perspective of Amalgam and Other Dental Materials. International Symposium Proceedings Stuttgart/New-York; Thieme 1995: 98-105
-
119
Pendergrass J C, Haley B E, Vimy M J. et al .
Mercury vapor inhalation inhibits binding of GTP to tubulin in rat brain: similarity to a molecular lesion in Alzheimer diseased brain.
Neurotoxicology.
1997;
18
315-324
-
120
Leong C C, Syed N I, Lorscheider F L.
Retrograde degeneration of neurite membrane structural integrity of nerve growth cones following in vitro exposure to mercury.
Neuroreport.
2001;
12
733-737
-
121
Cedrola S, Guzzi G, Ferrari D. et al .
Inorganic mercury changes the fate of murine CNS stem cells.
FASEB J.
2003;
17
869-871
-
122
Godfrey M E, Wojcik D P, Krone C A.
Apolipoprotein E genotyping as a potential biomarker for mercury neurotoxicity.
J Alzheimers Dis.
2003;
5
189-195
-
123
Ehmann W D, Markesbery W R, Alauddin M. et al .
Brain trace elements in Alzheimer’s disease.
Neurotoxicology.
1986;
7
195-120
-
124
Thompson C M, Markesbery W R, Ehmann W D. et al .
Regional brain trace-element studies in Alzheimer’s disease.
Neurotoxicology.
1988;
9
1-7
-
125
Wenstrup D, Ehmann W D, Markesbery W R.
Trace element imbalances in isolated subcellular fractions of Alzheimer’s disease.
Brain Res.
1990;
533
125-131
-
126
Cornett C R, Ehmann W D, Wekstein D R. et al .
Trace elements in Alzheimer’s disease pituitary glands.
Biol Trace Elem Res.
1998;
62 (1 - 2)
107-114
-
127
Samudralwar D L, Diprete C C, Ni B F. et al .
Elemental imbalances in the olfactory pathway in Alzheimer’s disease.
J Neurol Sci.
1995;
130
139-145
-
128
Basun H, Forssell L G, Wetterberg L. et al .
Metals and trace elements in plasma and cerebrospinal fluid in normal aging and Alzheimer’s disease.
J Neural Transm [P-D Sect].
1991;
3
231-258
-
129
Hock C, Drasch G, Golombowski S. et al .
Increased blood mercury levels in patients with Alzheimer’s disease.
J Neural Transm.
1998;
105
59-68
-
130 Braak H, Braak E, Yilmazer D. et al .Age-related changes of the human cerebral cortex. Cruz-Sanchez FF, Ravid R, Cuzner ML Neuropathological diagnostic criteria for brain banking Amsterdam; Biomedical Health Research IOS Press 1995: 14-19
-
131
Braak H, Griffing K, Braak E.
Neuroanatomy of Alzheimer’s disease.
Alzheimer’s Res.
1997;
3
235-247
-
132
Braak E, Griffing K, Arai K. et al .
Neuropathology of Alzheimer’s disease: what is new since A. Alzheimer?.
Eur Arch Psychiatry Clin Neurosci.
1999;
249 (Suppl 3)
14-22
-
133
Bickel H.
Dementia syndrome and Alzheimer disease: an assessment of morbidity and annual incidence in Germany.
Gesundheitswesen.
2000;
62
211-218
-
134
Miech R A, Breitner J C, Zandi P P. et al .
Incidence of AD may decline in the early 90 s for men, later for women: The Cache County study.
Neurology.
2002;
58
209-218
-
135
Haidinger G, Binder H, Kunze M.
Epidemiologic progression of dementia diseases in Austria until the year 2050.
Gesundheitswesen.
1992;
54
162-166
-
136
Lund J P, Mojon P, Pho M. et al .
Alzheimer’s disease and edentulism.
Age Ageing.
2003;
32
228-229
-
137
Saxe S R, Snowdon D A, Wekstein M W. et al .
Dental amalgam and cognitive function in older women: findings from the Nun Study.
J Am Dent Assoc.
1995;
126
1495-1501
-
138
Ahlqwist M, Bengtsson C, Furunes B. et al .
Number of amalgam tooth fillings in relation to subjectively experienced symptoms in a study of Swedish women.
Community Dent Oral Epidemiol.
1988;
16
227-231
-
139
Ahlqwist M, Bengtsson C, Lapidus L. et al .
Serum mercury concentration in relation to survival, symptoms, and diseases: results from the prospective population study of women in Gothenburg, Sweden.
Acta Odontol Scand.
1999;
57
168-174
-
140
Ahlqwist M, Bengtsson C, Lapidus L.
Number of amalgam fillings in relation to cardiovascular disease, diabetes, cancer and early death in Swedish women.
Community Dent Oral Epidemiol.
1993;
21
40-44
-
141
Bjorkman L, Pedersen N L, Lichtenstein P.
Physical and mental health related to dental amalgam fillings in Swedish twins.
Community Dent Oral Epidemiol.
1996;
24
260-267
-
142
Finefrock A E, Bush A I, Doraiswamy P M.
Current status of metals as therapeutic targets in Alzheimer’s disease.
J Am Geriatr Soc.
2003;
51
1143-1148
-
143
Ritchie C W, Bush A I, Mackinnon A. et al .
Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial.
Arch Neurol.
2003;
60
1685-1691
-
144
Razagui I B, Haswell S J.
Mercury and selenium concentrations in maternal and neonatal scalp hair: relationship to amalgam-based dental treatment received during pregnancy.
Biol Trace Elem Res.
2001;
81
1-19
-
145
Soderstrom S, Fredriksson A, Dencker L. et al .
The effect of mercury vapour on cholinergic neurons in the fetal brain: studies on the expression of nerve growth factor and its low- and high-affinity receptors.
Brain Res Dev Brain Res.
1995;
85
96-108
-
146
Szasz A, Barna B, Gajda Z. et al .
Effects of continuous low-dose exposure to organic and inorganic mercury during development on epileptogenicity in rats.
Neurotoxicology.
2002;
23
197-206
-
147
Bernard S, Enayati A, Roger H. et al .
The role of mercury in the pathogenesis of autism.
Mol Psychiatry.
2002;
7 (Suppl 2)
S42-S43
-
148
Geier D A, Geier M R.
A comparative evaluation of the effects of MMR immunization and mercury doses from thimerosal-containing childhood vaccines on the population prevalence of autism.
Med Sci Monit.
2004;
10
PI33-39
-
149
Geier D A, Geier M R.
An assessment of the impact of thimerosal on childhood neurodevelopmental disorders.
Pediatr Rehabil.
2003;
6
97-102
-
150
Geier M R, Geier D A.
Neurodevelopmental disorders after thimerosal-containing vaccines: a brief communication.
Exp Biol Med.
2003;
228
660-664
-
151
Geier M R, Geier D A.
Thiomersal in childhood vaccines, neurodevelopment disorders, and heart disease in the United States.
J Am Phys Surg.
2003;
8
6-11
-
152
Harakeh S, Sabra N, Kassak K. et al .
Mercury and arsenic levels among Lebanese dentists: a call for action.
Bull Environ Contam Toxicol.
2003;
70
629-635
-
153
Tezel H, Ertas O S, Erakin C. et al .
Blood mercury levels of dental students and dentists at a dental school.
Br Dent J.
2001;
191
449-452
-
154
Bittner A C Jr, Echeverria D, Woods J S. et al .
Behavioral effects of low-level exposure to Hg0 among dental professionals: a cross-study evaluation of psychomotor effects.
Neurotoxicol Teratol.
1998;
20
429-439
-
155
Echeverria D, Heyer N J, Martin M D. et al .
Behavioral effects of low-level exposure to elemental Hg among dentists.
Neurotoxicol Teratol.
1995;
17
161-168
-
156 Yoshida M, Watanabe C, Satoh M. et al .Susceptibility of Metallothionein-Null Mice to the Behavioural Alterations Caused by Exposure to Mercury Vapour at Human-Relevant Concentration. Toxicol Sci 2004 [Epub ahead of print]
-
157
Siblerud R L.
A comparison of mental health of multiple sclerosis patients with silver/mercury dental fillings and those with fillings removed.
Psychol Rep.
1992;
70
1139-1151
-
158
Siblerud R L.
The relationship between mercury from dental amalgam and mental health.
Am J Psychother.
1989;
43
575-587
-
159
Siblerud R L, Kienholz E, Motl J.
Evidence that mercury from silver dental fillings may be an etiological factor in smoking.
Toxicol Lett.
1993;
68
307-310
-
160
Siblerud R L, Motl J, Kienholz E.
Psychometric evidence that mercury from silver dental fillings may be an etiological factor in depression, excessive anger, and anxiety.
Psychol Rep.
1994;
74
67-80
-
161
Urban P, Gobba F, Nerudova J. et al .
Color discrimination impairment in workers exposed to mercury vapor.
Neurotoxicology.
2003;
24
711-716
-
162
Aydin N, Karaoglanoglu S, Yigit A. et al .
Neuropsychological effects of low mercury exposure in dental staff in Erzurum, Turkey.
Int Dent J.
2003;
53
85-91
-
163
Ngim C H, Foo S C, Boey K W. et al .
Chronic neurobehavioural effects of elemental mercury in dentists.
Br J Ind Med.
1992;
49
782-790
-
164
Ritchie K A, Gilmour W H, Macdonald E B. et al .
Health and neuropsychological functioning of dentists exposed to mercury.
Occup Environ Med.
2002;
59
287-293
-
165
Nadorfy-Lopez E, Torres S H, Finol H. et al .
Skeletal muscle abnormalities associated with occupational exposure to mercury vapours.
Histol Histopathol.
2000;
15
673-682
-
166
Urban P, Lukas E, Nerudova J. et al .
Neurological and electrophysiological examinations on three groups of workers with different levels of exposure to mercury vapors.
Eur J Neurol.
1999;
6
571-577
-
167
Meyer-Baron M, Schaeper M, Seeber A.
A meta-analysis for neurobehavioural results due to occupational mercury exposure.
Arch Toxicol.
2002;
76
127-136
-
168
Dunsche A, Frank M P, Luttges J. et al .
Lichenoid reactions of murine mucosa associated with amalgam.
Br J Dermatol.
2003;
148
41-748
-
169
Dunsche A, Kastel I, Terheyden H. et al .
Oral lichenoid reactions associated with amalgam: improvement after amalgam removal.
Br J Dermatol.
2003;
148
70-76
-
170
Martin M D, Broughton S, Drangsholt M.
Oral lichen planus and dental materials: a case-control study.
Contact Dermatitis.
2003;
48
331-336
-
171
Wong L, Freeman S.
Oral lichenoid lesions (OLL) and mercury in amalgam fillings.
Contact Dermatitis.
2003;
48
74-79
-
172
Guttman-Yassky E, Weltfriend S, Bergman R.
Resolution of orofacial granulomatosis with amalgam removal.
J Eur Acad Dermatol Venereol.
2003;
17
344-347
-
173
Gerhard I, Monga B, Waldbrenner A. et al .
Heavy metals and fertility.
J Toxicol Environ Health A.
1998;
54
593-611
-
174
Gerhard I, Runnebaum B.
[The limits of hormone substitution in pollutant exposure and fertility disorders].
Zentralbl Gynakol.
1992;
114
593-602
-
175
Gerhard I, Waibel S, Daniel V. et al .
Impact of heavy metals on hormonal and immunological factors in women with repeated miscarriages.
Hum Reprod Update.
1998;
4
301-309
-
176
Rowland A S, Baird D D, Weinberg C R. et al .
The effect of occupational exposure to mercury vapour on the fertility of female dental assistants.
Occup Environ Med.
1994;
51
28-34
-
177
Sheiner E K, Sheiner E, Hammel R D. et al .
Effect of occupational exposures on male fertility: literature review.
Ind Health.
2003;
41
55-62
-
178
Podzimek S, Prochazkova J, Pribylova L. et al .
[Effect of heavy metals on immune reactions in patients with infertility].
Cas Lek Cesk.
2003;
142
285-288
-
179
Frustaci A, Magnavita N, Chimenti C. et al .
Marked elevation of myocardial trace elements in idiopathic dilated cardiomyopathy compared with secondary cardiac dysfunction.
J Am Coll Cardiol.
1999;
33
1578-1583
-
180
Lorscheider F, Vimy M.
Mercury and idiopathic dilated cardiomyopathy.
J Am Coll Cardiol.
2000;
35
819-820
-
181
Guallar E, Sanz-Gallardo M I, van’t V eer P. et al .
Heavy Metals and Myocardial Infarction Study Group. Mercury, fish oils, and the risk of myocardial infarction.
N Engl J Med.
2002;
347
1747-1754
-
182
Salonen J T, Seppanen K, Nyyssonen K. et al .
Intake of mercury from fish, lipid peroxidation, and the risk of myocardial infarction and coronary, cardiovascular, and any death in eastern Finnish men.
Circulation.
1995;
91
645-655
-
183
Moreira C M, Oliveira E M, Bonan C D. et al .
Effects of mercury on myosin ATPase in the ventricular myocardium of the rat.
Comp Biochem Physiol C Toxicol Pharmacol.
2003;
135C
269-275
-
184
de Assis G P, Silva C E, Stefanon I. et al .
Effects of small concentrations of mercury on the contractile activity of the rat ventricular myocardium.
Comp Biochem Physiol C Toxicol Pharmacol.
2003;
134
375-383
-
185
South P K, Morris V C, Levander O A. et al .
Mortality in mice infected with an amyocarditic coxsackievirus and given a subacute dose of mercuric chloride.
J Toxicol Environ Health A.
2001;
63
511-523
-
186
Boffetta P, Sallsten G, Garcia-Gomez M. et al .
Mortality from cardiovascular diseases and exposure to inorganic mercury.
Occup Environ Med.
2001;
58
461-466
-
187
Siblerud R L.
The relationship between mercury from dental amalgam and the cardiovascular system.
Sci Total Environ.
1990;
99
23-35
-
188
Craelius W.
Comperative epidemiology of multiple sclerosis and dental caries.
Journal of Epidemiol Comm Health.
1978;
32
155-165
-
189
McGrother C W, Dugmore C, Phillips M J. et al .
Multiple sclerosis, dental caries and fillings: a case-control study.
Br Dent J.
1999;
187
261-264
-
190
Baasch E.
Theoretical considerations on the etiology of multiple sclerosis. Is multiple sclerosis a mercury allergy?.
Schweiz Arch Neurol Neurochir Psychiatr.
1966;
98
1-19
-
191
Ingalls T H.
Epidemiology, etiology, and prevention of multiple sclerosis. Hypothesis and fact.
Am J Forensic Med Pathol.
1983;
4
55-61
-
192
Ingalls T H.
Endemic clustering of multiple sclerosis in time and place, 1934 - 1984. Confirmation of a hypothesis.
Am J Forensic Med Pathol.
1986;
7
3-8
-
193
Issa Y, Watts D C, Duxbury A J. et al .
Mercuric chloride: toxicity and apoptosis in a human oligodendroglial cell line MO3.13.
Biomaterials.
2003;
24
981-987
-
194
Ahlrot-Westerlund B.
Mercury in cerebrospinal fluid in multiple sclerosis.
Swed J Biol Med.
1989;
1
6-7
-
195
Siblerud R L, Kienholz E.
Evidence that mercury from silver dental fillings may be an etiological factor in multiple sclerosis.
Sci Total Environ.
1994;
142
191-205
-
196
Huggins H A, Levy T E.
Cerebrospinal fluid protein changes in multiple sclerosis after dental amalgam removal.
Altern Med Rev.
1998;
3
295-300
-
197
Engel P.
[Observations on health before and after amalgam removal].
Schweiz Monatsschr Zahnmed.
1998;
108
811-813
-
198
Prochazkova J, Sterzl I, Kucerova H. et al .
The beneficial effects of amalgam replacement on health of patients with autoimmunity.
Neuroendocrinol Lett.
2004;
25
211-218
-
199
Casetta I, Invernizzi M, Granieri E.
Multiple sclerosis and dental amalgam: case-control study in Ferrara, Italy.
Neuroepidemiology.
2001;
20
134-137
-
200
Bangsi D, Ghadirian P, Ducic S. et al .
Dental amalgam and multiple sclerosis: a case-control study in Montreal, Canada.
Int J Epidemiol.
1998;
27
667-671
-
201
Bates N M, Fawcett J, Garrett N. et al .
Health effects of dental amalgam exposure: a retrospective cohort study.
Int J Epidemiol.
2004;
33
894-902
-
202
Pamphlett R, Slater M, Thomas S.
Oxidative damage to nuclic acids in motor neurons containing mercury.
J Neurol Sci.
1998;
159
121-126
-
203
Pamphlett R, Waley P.
Motor neuron uptake of low dose inorganic mercury.
J Neurol Sci.
1996;
135
63-67
-
204
Adams C R, Ziegler D K, Lin J T.
Mercury intoxication simulating amyotrophic lateral sclerosis.
JAMA.
1983;
250
642-643
-
205
Schwarz S, Husstedt I, Bertram H P. et al .
Amyotrophic lateral sclerosis after accidental injection of mercury.
J Neurol Neurosurg Psychiatry.
1996;
60
698
-
206
Rehde O, Pleva J.
Recovery from amyothrophic lateral sclerosis and from allergy after removal of dental amalgam fillings.
Int J Risk Safety Med.
1994;
4
229-236
-
207
Lindh U, Hudecek R, Danersund A. et al .
Removal of dental amalgam and other metal alloys supported by antioxidant therapy alleviates symptoms and improves quality of life in patients with amalgam-associated ill health.
Neuroendocrinol Lett.
2002;
23
459-482
-
208
Marcusson J A.
Psychological and somatic subjective symptoms as a result of dermatological patch testing with metallic mercury and phenyl mercuric acetate.
Toxicol Lett.
1996;
84
113-122
-
209
Marcusson J A, Jarstrand C.
Oxidative Metabolism of neutrophils in vitro and human mercury intolerance.
Toxicol In vitro.
1998;
12
383-388
-
210
Marcusson J A, Carlmark B, Jarstrand C.
Mercury intolerance in relation to superoxide dismutase, glutathione peroxidase, catalase, and the nitroblue tetrazolium responses.
Environ Res.
2000;
83
123-128
-
211
Stewart W F, Schwartz B S, Simon D. et al .
ApoE genotype, past adult lead exposure, and neurobehavioral function.
Environ Health Perspect.
2002;
110
501-505
-
212
Hol P J, Vamnes J S, Gjerdet N R. et al .
Dental amalgam and selenium in blood.
Environ Res.
2001;
87
141-146
-
213
Lindh U, Carlmark B, Gronquist S O. et al .
Metal exposure from amalgam alters the distribution of trace elements in blood cells and plasma.
Clin Chem Lab Med.
2001;
39
134-142
-
214
Stejskal V D, Forsbeck M, Cederbrant K E. et al .
Mercury-specific lymphocytes: an indication of mercury allergy in man.
J Clin Immunol.
1996;
16
31-40
-
215
Valentine-Thon E, Schiwara H W.
Validity of MELISA for metal sensitivity testing.
Neuroendocrinol Lett.
2003;
24
57-64
-
216
Bauer A, Alsen-Hinrichs C, Wassermann O.
[Evaluation of environmental medicine documentation in Schleswig-Holstein 1995 - 1999].
Gesundheitswesen.
2001;
63
231-237
-
217 Hamre H J. Amalgam. Stuttgart; Hippokrates-Verlag 1997
-
218
Kidd R F.
Results of dental amalgam removal and mercury detoxification using DMPS and neural therapy.
Altern Ther Health Med.
2000;
6
49-55
-
219
Melchart D, Wuhr E, Weidenhammer W. et al .
A multicenter survey of amalgam fillings and subjective complaints in non-selected patients in the dental practice.
Eur J Oral Sci.
1998;
106
770-777
-
220 Berlin M. Mercury in dental-filling materials - an updated risk analysis in environmental medical terms. The dental Material Commission- Care and Consideration. 2003. Available from: URL: http://www.dentalmaterial.gov.se/mercury.pdf [cited 2003 September 22]: 19.
-
221 Engel P. Migräne- eine unheilbare Krankheit? 2003. Available at URL: http://www.amalgam-info.ch/mig_d.pdf [cited 16.1.04].
-
222
Bailer J, Staehle H J, Rist F.
[Ill due to amalgam? 10 rules for managing the symptomatic patient].
MMW Fortschr Med.
2003;
145
34-38
-
223
Bailer J, Rist F, Rudolf A. et al .
Adverse health effects related to mercury exposure from dental amalgam fillings: toxicological or psychological causes?.
Psychol Med.
2001;
31
255-263
-
224 Wassermann O, Weitz M, Alsen-Hinrichs C. Kieler Amalgamgutachten 1997. Institut für Toxikologie. Kiel; Christian-Albrechts-Universität 1997 2. Aufl
-
225 Ruprecht J. Dimaval (DMPS)/DMPS-Heyl - wissenschaftliche Produktmonographie. 6. aktualisierte und erweiterte Auflage. 1997
-
226 Price W A. Nutrition and physical degeneration. 6th edition. McGraw Hill; NTC 1998
-
227
Saxe S R, Wekstein M W, Kryscio R J. et al .
Alzheimer’s disease, dental amalgam and mercury.
J Am Dent Assoc.
1999;
130
191-199
-
228
Walach H, Naumann J, Mutter J. et al .
No difference between self-reportedly amalgam sensitives and non-sensitives? Listen carefully to the data.
Int J Hyg Environ Health.
2003;
206
139-141
-
229
Mutter J, Daschner F D.
Commentary regarding the article by Gottwald et al.: „Amalgam disease” - poisoning, allergy, or psychic disorder?.
Int J Hyg Environ Health.
2003;
206
69-70
-
230 Burton D. Consumer Choice and implementing full disclosure in dentistry „... Amalgam must be considered to be an unsuitable material for dental restoration”. 2003. Available at URL. http://www.house.gov/burton/pr5703 [cited 16.1.04].
-
231 Burton D. Mercury in Medicine-Taking unnecessary Risks. 2003. Available at URL. http://www.house.gov/burton/pr5203 [cited 16.1.04].
-
232 House of Representatives .H.R. 1680: A Bill. Mercury in Dental Filling Disclosure and Prohibition Act. 2003. Available at URL: http://thomas.loc.gov/cgi-bin/query/z?c108: H.R.1680.IH: [cited 16.1.04].
-
233 ADA .H.R. 1680. Association urges House members to reject amalgam-banning legislation. 2003. Available at URL: http://www.ada.org/prof/resources/pubs/adanews/adanewsarticle.asp?articleid = 235 [cited 20.2.2004].
-
234 BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte) .Amalgame in der zahnärztlichen Therapie. 2003. Available from: URL: http://www.bfarm.de/de/DasBfArM/publ/Broschuere_Amalgame.pdf [cited 2003 November 6].
-
235
Harhammer R.
Zur Risikobewertung des zahnärztlichen Füllungswerkstoffes Amalgam.
Bundesgesundhbl.
2001;
44
149-154
-
236
Larkin M.
Don’t remove amalgam fillings, urges American Dental Association.
Lancet.
2002;
360
393
-
237
Yip H K, Li D K, Yau D C.
Dental amalgam and human health.
Int Dent J.
2003;
53
464-468
-
238 UNEP (United Nations Environment Program (Chemicals) .Global Mercury Assesment. UNEP Chemicals Geneva. 2002. Available from: URL: http://www.unep.org/GoverningBodies/GC22/Document/UNEP-GC22-INF3.pdf [cited 2003 September 22].
-
239
Schober S E, Sinks T H, Jones R L. et al .
Blood mercury levels in US children and women of childbearing age, 1999 - 2000.
JAMA.
2003;
289
1667-1674
-
240 Bender M T. Dentists the menace? The uncontrolled release of dental mercury. Mercury policy project. 2002. Available from: URL: http://www.mercurypolicy.org/new/documents/DentistTheMenace.pdf [cited 2003 September 22].
-
241 Department o f Ecology Publication. Draft for public comment. Washington State mercury chemical action plan. 2002. Available from: URL: http://www.ecy.wa.gov/pubs/0 203 042.pdf [cited 2003 December 16].
-
242
Stone M E, Cohen M E, Liang L. et al .
Determination of methyl mercury in dental-unit wastewater.
Dent Mater.
2003;
19
675-679
-
243
Leistevuo J, Leistevuo T, Helenius H. et al .
Mercury in saliva and the risk of exceeding limits for sewage in relation to exposure to amalgam fillings.
Arch Environ Health.
2002;
57
366-370
-
244
Künzler P, Andrée M.
More mercury from crematoria.
Nature.
1991;
349
746-747
-
245
Maloney S R, Phillips C A, Mills A.
Mercury in the hair of crematoria workers.
Lancet.
1998;
352
1602
-
246
Mills A.
Mercury and crematorium.
Nature.
1990;
346
615
-
247
Kornhuber H H.
Prevention of dementia (including Alzheimer’s disease).
Gesundheitswesen.
2004;
66
346-351
-
248 Life Science Research Office .Final Report. 2004. Available from: URL: http://www.Lsro.org/amalgam/frames_amalgam_report.html [cited 2005, January 22]+;.
Dr. med. Joachim Mutter
Institut für Umweltmedizin und Krankenhaushygiene, Universitätsklinik Freiburg
Hugstetter Str. 55
79106 Freiburg
Email: joachim.mutter@uniklinik-freiburg.de